OSI Pharmaceuticals, Inc., Roche Holding AG’s Tarceva Helps Keep Lung Cancer from Worsening-Study

Reuters -- Lung cancer drug Tarceva was significantly better than a placebo in keeping the disease from worsening in patients whose cancer had not progressed after treatment with platinum-based chemotherapy, according to a late-stage clinical trial.